AvianInfluenzaMarch23

From PVSG
Revision as of 18:37, 1 March 2023 by Paul (talk | contribs) (Created page with "<center> <font size = "+3"> <font color="#0000A0"> The Poultry Veterinary Study Group of the EU </font color> </font size> </center> <HR>...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

The Poultry Veterinary Study Group of the EU


                                                                    1st March 2023


Dear Sir/Madam,

On behalf of The Poultry Veterinary Study Group of the EU please find, linked below, our position paper entitled "Highly Pathogenic Avian Influenza and vaccinal strategy implementation".

The Poultry Veterinary Study Group of the EU in its previous position paper ‘Highly Pathogenic Avian Influenza and sustainability of the global poultry industry’ proposed that governments and industry should seriously consider the options to use modern vaccines to control Highly Pathogenic Avian Influenza (HPAI) particularly as in some circumstances the classical approach of management of this disease (i.e., diagnosis, stamping out and eradication) alone , is no longer socially and economically acceptable to poultry producers and wider stakeholders.

The attached paper summarises PVSGEU's current position on the use of vaccination to control HPAI.

Yours Sincerely

Dr. Eva Berndtson

President of PVSGEU


PVSG Working Group on Avian Influenza (February 2023)

Matthias Voss (Chair), Soeren Astrup (Denmark), Eija Kaukonen (Finland), Sabine Breul, Leni Corrand, Gerard Leveque (France), Matthias Todte, Borris Meyer-Kuehling (Germany), Daniel Parker (Great Britain), Laszlo Korosi (Hungary), Mauro Castello (Italy), Ovsana Mikhaylovskaya (Latvia), Peter Wijnen, Sjaak de Wit (Netherlands), Marcin Andrzejewski (Poland) Mihai Vlad Duma (Romania), Pablo Catala (Spain), Pia Gustavsson (Sweden)


Click here for the Position Paper